Medical Advocates
ARV/HAART/cART
  First Line Drug-Specific Regimens

 Efavirenz-Based Regimens
Indinavir-Based Regimens
Lopinavir/Ritonavir-Based Regimens
Nelfinavir-Based Regimens
Nevirapine-Based Regimens
Ritonavir-Based Regimens
Saquinavir-Based Regimens
Stavudine-Based Regimens
ZDV/3TC-Based Regimens
 Miscellaneous Regimens
ARV-Naive Main Page Main New/Newsworthy  Home Page      
Last Update:  September 02, 2016
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Efavirenz-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
  A prospective comparison of the two main indications of efavirenz in 2001 highly active
antiretroviral therapy (HAART) regimens: first-line versus
salvage use.
Manfredi R, Calza L, Chiodo F.
 J Antimicrob Chemother 2002 May;49(5):723-9
 Abstract

Evaluation of an efavirenz-containing regimen: an open-label, multicenter study.
Hartmann M, Rump A, Brust J, et al
 HIV Clin Trials 2001 Sep-Oct;2(5):421-8
 Abstract

Response to first protease inhibitor- and efavirenz-containing antiretroviral combination
therapy The Swiss HIV Cohort Study.
Friedl AC, Ledergerber B, Flepp M, et al
AIDS 2001 Sep 28;15(14):1793-1800
Abstract

  
Indinavir-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
  Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 100-mg Regimen in Protease
Inhibitor-Naive HIV-Infected Adults.
 Young B, Fischl MA, Wilson HM, et al.  
 J Acquir Immune Defic Syndr 2002 Dec 15;31(5):478-82
 Abstract		  
Lopinavir-Based Regimens
   
LPV/RTV/D4T/3TC

     Journal Papers, Abstracts, and Commentaries

  ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-
naive adults
with HIV-1 infection: 48-week results.
Murphy RL, et al.
AIDS 2001 Jan 5;15(1):F1-9
Abstract		  

LPV/RTV vs Nelfinavir

     Journal Papers, Abstracts, and Commentaries
 
  Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
Walmsley S, Bernstein B, King M, et al.
N Engl J Med 2002 Jun 27;346(26):2039-46
 Abstract 		 
Nelfinavir-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
  Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
Walmsley S, Bernstein B, King M, et al.
N Engl J Med 2002 Jun 27;346(26):2039-46
 Abstract
 
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/
lamivudine in HIV-infected naive patients (the Combine Study).
 Podzamczer D, Ferrer E, Consiglio E, et al
 Antivir Ther 2002 Jun;7(2):81-90
 Abstract
 
Nevirapine Therapies
   
     Journal Papers, Abstracts, and Commentaries
 
 
A randomized clinical trial comparing nelfinavir or nevirapine associated to
zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
 Podzamczer D, Ferrer E, Consiglio E, et al
 Antivir Ther 2002 Jun;7(2):81-90
 Abstract
 
Ritonavir-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
 
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase
inhibitors in a German multicentre study: 48-week results.
Voigt E, Wickesberg A, Wasmuth JC, et al.
HIV Med 2002 Oct;3(4):277-82
 Abstract

Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in
combination with two nucleoside reverse transcriptase inhibitors as first line
antiretroviral therapy.
Lichterfeld M, Nischalke HD, Bergmann F, et al
 Abstract

 
Saquinavir--Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
  MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity
and safety of saquinavir with stavudine and zalcitabine.
Katlama C, Pellegrin JL, Lacoste D,  et al.
HIV Med 2001 Jan;2(1):20-6
 Abstract 		 
Stavudine-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
  Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency
virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and
lamivudine.
Picard V, Angelini E, Maillard A, et al.
J Infect Dis 2001 Sep 15;184(6):781-4
 Abstract 		 
ZDV/3TC-Based Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
 
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/
lamivudine in HIV-infected naive patients (the Combine Study).
Podzamczer D, Ferrer E, Consiglio E, et al
 Antivir Ther 2002 Jun;7(2):81-90
 Abstract

Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency
virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and
lamivudine.
 Picard V, Angelini E, Maillard A, et al.
 J Infect Dis 2001 Sep 15;184(6):781-4
 Abstract

 Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human
immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase
codon 215 mutant in circulating lymphocytes and free virus.
 Trabaud MA, Leriche-Guerin K, Regis C, et al
 Med Virol 2000 Jul;61(3):352-9
 Abstract

  
Miscellaneous Regimens
   
     Journal Papers, Abstracts, and Commentaries
 
 
Complementary and alternative therapy (CAT) use and highly active antiretroviral therapy (HAART):
current evidence in the literature, 2000-2009.
Hoogbruin A.
J Clin Nurs. 2011 Feb 9.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
 Potential use of rapamycin in HIV infection.
Donia M, McCubrey JA, Bendtzen K, Nicoletti F
 Br J Clin Pharmacol. 2010 Dec;70(6):784-93.
 Paper

Potential use of rapamycin in HIV infection.
Donia M, McCubrey JA, Bendtzen K, Nicoletti F.
Br J Clin Pharmacol. 2010 Dec;70(6):784-93.
 Abstract

  

 

ARV-Naive Main Page Main New/Newsworthy  Home Page      

 First-Line Drug-Specific  ARV Regimens